[1]
N. Gunja and A. Graudins, ‘Management of cardiac arrest following poisoning’, Emergency Medicine Australasia, vol. 23, no. 1, pp. 16–22, Feb. 2011, doi: 10.1111/j.1742-6723.2010.01369.x.
[2]
T. B. Hendry-Hofer et al., ‘A Review on Ingested Cyanide: Risks, Clinical Presentation, Diagnostics, and Treatment Challenges’, Journal of Medical Toxicology, Dec. 2018, doi: 10.1007/s13181-018-0688-y.
[3]
V. Jha and K. Padmaprakash, ‘Extracorporeal treatment in the management of acute poisoning: What an intensivist should know?’, Indian Journal of Critical Care Medicine, vol. 22, no. 12, 2018, doi: 10.4103/ijccm.IJCCM_425_18.
[4]
K. Phillips, A. Luk, G. S. Soor, J. R. Abraham, S. Leong, and J. Butany, ‘Cocaine Cardiotoxicity’, American Journal of Cardiovascular Drugs, vol. 9, no. 3, pp. 177–196, Jun. 2009, doi: 10.1007/BF03256574.
[5]
D. N. Bateman, ‘Paracetamol poisoning: beyond the nomogram’, British Journal of Clinical Pharmacology, vol. 80, no. 1, pp. 45–50, Jul. 2015, doi: 10.1111/bcp.12604.
[6]
D. N. Bateman et al., ‘Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial’, The Lancet, vol. 383, no. 9918, pp. 697–704, Feb. 2014, doi: 10.1016/S0140-6736(13)62062-0.
[7]
‘Paracetamol overdose - RCEMLearning’. [Online]. Available: https://www.rcemlearning.co.uk/foamed/paracetamol-overdose-2/
[8]
‘Pharmacology and Toxicology: Treatment of Poisons - Salicylate Intoxication - Renal and Urology News’. [Online]. Available: https://www.renalandurologynews.com/nephrology-hypertension/pharmacology-and-toxicology-treatment-of-poisons--salicylate-intoxication/article/616622/
[9]
‘Salicylate Toxicity - REBEL EM - Emergency Medicine Blog’. [Online]. Available: http://rebelem.com/salicylate-toxicity/
[10]
L. K. Weaver, ‘Carbon Monoxide Poisoning’, New England Journal of Medicine, vol. 360, no. 12, pp. 1217–1225, Mar. 2009, doi: 10.1056/NEJMcp0808891.
[11]
‘Guidelines for the Management of Excited Delirium/Acute Behavioural Disturbance’. [Online]. Available: https://www.rcem.ac.uk/docs/College%20Guidelines/5p.%20RCEM%20guidelines%20for%20management%20of%20Acute%20Behavioural%20Disturbance%20(May%202016).pdf
[12]
N. A. Buckley, A. H. Dawson, and G. K. Isbister, ‘Serotonin syndrome’, BMJ, vol. 348, no. feb19 6, pp. g1626–g1626, Feb. 2014, doi: 10.1136/bmj.g1626.
[13]
S.-S. Sim and J.-T. Sun, ‘Ocular Flutter in the Serotonin Syndrome’, New England Journal of Medicine, vol. 375, no. 18, Nov. 2016, doi: 10.1056/NEJMicm1506066.
[14]
‘CBRN Handbook’. [Online]. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/712888/Chemical_biological_radiological_and_nuclear_incidents_clinical_management_and_health_protection.pdf
[15]
H. Hughes, R. Peters, G. Davies, and K. Griffiths, ‘A study of patients presenting to an emergency department having had a “spiked drink”’, Emergency Medicine Journal, vol. 24, no. 2, pp. 89–91, Feb. 2007, doi: 10.1136/emj.2006.040360.
[16]
P. Quigley, D. M. Lynch, M. Little, L. Murray, A.-M. Lynch, and S. J. O’Halloran, ‘Prospective study of 101 patients with suspected drink spiking’, Emergency Medicine Australasia, vol. 21, no. 3, pp. 222–228, Jun. 2009, doi: 10.1111/j.1742-6723.2009.01185.x.
[17]
S. L. Greene et al., ‘What’s being used to spike your drink? Alleged spiked drink cases in inner city London’, Postgraduate Medical Journal, vol. 83, no. 986, pp. 754–758, Dec. 2007, doi: 10.1136/pgmj.2007.059048.
[18]
R. Duncan and S. Thakore, ‘Decreased Glasgow Coma Scale Score Does Not Mandate Endotracheal Intubation in the Emergency Department’, The Journal of Emergency Medicine, vol. 37, no. 4, pp. 451–455, Nov. 2009, doi: 10.1016/j.jemermed.2008.11.026.
[19]
N. Eizadi-Mood et al., ‘Comparative evaluation of Glasgow Coma Score and gag reflex in predicting aspiration pneumonitis in acute poisoning’, Journal of Critical Care, vol. 24, no. 3, p. 470.e9-470.e15, Sep. 2009, doi: 10.1016/j.jcrc.2008.08.008.
[20]
‘Paediatric Toxicology Considerations - RCEMLearning’. [Online]. Available: https://www.rcemlearning.co.uk/modules/paediatric-toxicology-considerations/
[21]
‘Clinical Practice Guidelines : Iron poisoning’. [Online]. Available: https://www.rch.org.au/clinicalguide/guideline_index/Iron_poisoning/
[22]
J.-A. Rotella, ‘The Toxicological Risk Assessment’, Don’t Forget The Bubbles, Jul. 2018, doi: 10.31440/DFTB.16255.
[23]
A. Kasturiratne et al., ‘The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths’, PLoS Medicine, vol. 5, no. 11, Nov. 2008, doi: 10.1371/journal.pmed.0050218.
[24]
Darryl Wood, ‘Classifying snakebite in South Africa: Validating a scoring system’, South African Medical Journal, vol. 107, no. 1, 2016 [Online]. Available: http://www.samj.org.za/index.php/samj/article/view/11763/7911
[25]
E. M. A. Witherington, O. M. Pirzada, and A. J. Avery, ‘Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study’, Quality and Safety in Health Care, vol. 17, no. 1, pp. 71–75, Feb. 2008, doi: 10.1136/qshc.2006.020842.
[26]
P. Gallagher and D. O’Mahony, ‘STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria’, Age and Ageing, vol. 37, no. 6, pp. 673–679, Oct. 2008, doi: 10.1093/ageing/afn197.
[27]
‘Beers Criteria - American Geriatric Society’. [Online]. Available: https://www.sigot.org/allegato_docs/1057_Beers-Criteria.pdf
[28]
‘Violence and aggression: short-term management in mental health, health and community settings | Guidance and guidelines | NICE’ [Online]. Available: https://www.nice.org.uk/guidance/ng10
[29]
‘ABD: Guidelines on management in police custody’. [Online]. Available: https://fflm.ac.uk/resources/publications/acute-behavioural-disturbance-abdguidelines-on-management-in-police-custody/
[30]
L. R. Klein et al., ‘Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department’, Annals of Emergency Medicine, vol. 72, no. 4, pp. 374–385, Oct. 2018, doi: 10.1016/j.annemergmed.2018.04.027.
[31]
B. PATERSON, P. BRADLEY, C. STARK, D. SADDLER, D. LEADBETTER, and D. ALLEN, ‘Deaths associated with restraint use in health and social care in the UK. The results of a preliminary survey’, Journal of Psychiatric and Mental Health Nursing, vol. 10, no. 1, pp. 3–15, Feb. 2003, doi: 10.1046/j.1365-2850.2003.00523.x.
[32]
G. M. Vilke, J. Payne-James, and S. B. Karch, ‘Excited delirium syndrome (ExDS): Redefining an old diagnosis’, Journal of Forensic and Legal Medicine, vol. 19, no. 1, pp. 7–11, Jan. 2012, doi: 10.1016/j.jflm.2011.10.006.
[33]
M. E. Musselman and S. Saely, ‘Diagnosis and treatment of drug-induced hyperthermia’, American Journal of Health-System Pharmacy, vol. 70, no. 1, pp. 34–42, Jan. 2013, doi: 10.2146/ajhp110543.
[34]
‘The prescription opioid addiction and abuse epidemic: how it happened and what we can do about it | Comment | Pharmaceutical Journal’. [Online]. Available: https://pharmaceutical-journal.com/article/opinion/the-prescription-opioid-addiction-and-abuse-epidemic-how-it-happened-and-what-we-can-do-about-it
[35]
Susanne Dreborg, Görel Sundström, Tomas A. Larsson and Dan Larhammar, ‘Evolution of Vertebrate Opioid Receptors’, Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, 2008 [Online]. Available: https://www.jstor.org/stable/25464438?pq-origsite=summon&seq=1#metadata_info_tab_contents
[36]
J. McDonald and D. Lambert, ‘Opioid receptors’, BJA Education, vol. 15, no. 5, pp. 219–224, Oct. 2015, doi: 10.1093/bjaceaccp/mku041.
[37]
K. A. Sporer, J. Firestone, and S. M. Isaacs, ‘Out-of-hospital Treatment of Opioid Overdoses in an Urban Setting’, Academic Emergency Medicine, vol. 3, no. 7, pp. 660–667, Jul. 1996, doi: 10.1111/j.1553-2712.1996.tb03487.x.
[38]
J. P. Wyatt, Oxford handbook of emergency medicine, Fourth edition. New York, New York: Oxford University Press, 2012 [Online]. Available: https://ebookcentral.proquest.com/lib/gmul-ebooks/detail.action?docID=1578266
[39]
A. Elms, ‘Goldfrank’s Toxicologic Emergencies’, Academic Emergency Medicine, vol. 18, no. 10, pp. e85–e85, Oct. 2011, doi: 10.1111/j.1553-2712.2011.01179.x.
[40]
‘LITFL Toxicology Library • LITFL Tox Library’. [Online]. Available: https://litfl.com/tox-library/
[41]
‘High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning’. [Online]. Available: http://crashingpatient.com/wp-content/uploads/2011/07/hiet-review.pdf
[42]
A. Graudins, H. M. Lee, and D. Druda, ‘Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies’, British Journal of Clinical Pharmacology, vol. 81, no. 3, pp. 453–461, Mar. 2016, doi: 10.1111/bcp.12763.
[43]
N. J. Johnson, D. F. Gaieski, S. R. Allen, J. Perrone, and F. DeRoos, ‘A Review of Emergency Cardiopulmonary Bypass for Severe Poisoning by Cardiotoxic Drugs’, Journal of Medical Toxicology, vol. 9, no. 1, pp. 54–60, Mar. 2013, doi: 10.1007/s13181-012-0281-8.
[44]
V. Boswell-Smith, D. Spina, and C. P. Page, ‘Phosphodiesterase inhibitors’, British Journal of Pharmacology, vol. 147, no. S1, pp. S252–S257, Feb. 2009, doi: 10.1038/sj.bjp.0706495.
[45]
T. A. Laack, K. M. Thompson, J. M. Kofler, M. F. Bellolio, M. D. Sawyer, and N. N. Issa Laack, ‘Comparison of Trauma Mortality and Estimated Cancer Mortality From Computed Tomography During Initial Evaluation of Intermediate-Risk Trauma Patients’, The Journal of Trauma: Injury, Infection, and Critical Care, vol. 70, no. 6, pp. 1362–1365, Jun. 2011, doi: 10.1097/TA.0b013e3181e1707f.
[46]
‘RCEM Alcohol A Toolkit for Improving Care 2015’. [Online]. Available: https://ranzetta.typepad.com/files/royal-college-of-emergency-medicine_alcohol---a-toolkit-for-improving-care.pdf
[47]
R. Rao and A. Roche, ‘Substance misuse in older people’, BMJ, Aug. 2017, doi: 10.1136/bmj.j3885.
[48]
M. J. Crawford et al., ‘Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial’, The Lancet, vol. 364, no. 9442, pp. 1334–1339, Oct. 2004, doi: 10.1016/S0140-6736(04)17190-0.
[49]
E. W. Boyer and M. Shannon, ‘The Serotonin Syndrome’, New England Journal of Medicine, vol. 352, no. 11, pp. 1112–1120, Mar. 2005, doi: 10.1056/NEJMra041867.
[50]
S. Prakash, C. Rathore, K. Rana, A. Dave, H. Joshi, and J. Patel, ‘Refining the clinical features of serotonin syndrome: A prospective observational study of 45 patients’, Annals of Indian Academy of Neurology, vol. 22, no. 1, 2019, doi: 10.4103/aian.AIAN_344_18.
[51]
‘Demystifying serotonin syndrome (or serotonin toxicity)’. [Online]. Available: http://www.cfp.ca/content/cfp/64/10/720.full.pdf
[52]
H. Nguyen, A. Pan, C. Smollin, L. F. Cantrell, and T. Kearney, ‘An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System’, Journal of Clinical Pharmacy and Therapeutics, vol. 44, no. 2, pp. 327–334, Apr. 2019, doi: 10.1111/jcpt.12796.
